As of November 6, 2026, 5 holders' latest Schedule 13D or 13G filings report owning 5% or more of TIAN RUIXIANG Holdings Ltd. The largest reported stake is Sinovation Fund IV, L.P.'s, at 21.19%. 8 filings are on record since July 8, 2025 (Schedule 13D, July 14, 2025).
Sell to companies like TIAN RUIXIANG Holdings Ltd? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Holder: Mitchell P. Kopin · Percent: 2.4% · SCHEDULE 13G/A
- · Holder: Mitchell P. Kopin · Percent: 9.99% · SCHEDULE 13G
- · Holder: Eastern Bell International XXVII Limited · Percent: 12.09% · SCHEDULE 13G
- · Holder: Lan Cheng · Percent: 11.7% · SCHEDULE 13G
- · Holder: Medata Holdings Limited · Percent: 16.68% · SCHEDULE 13D
TIAN RUIXIANG Holdings Ltd has 8 Schedule 13D or 13G filings on record since 2025-07-08. 5 holders' latest filing reports 5% or more of class a ordinary shares, par value $0.125 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Sinovation Fund IV, L.P. | 21.19% | 25,593,133 | SCHEDULE 13D, 2025-07-14 | 2025-06-30 |
| Medata Holdings Limited | 16.68% | 20,147,573 | SCHEDULE 13D, 2025-07-23 | 2025-06-30 |
| Eastern Bell International XXVII Limited | 12.09% | 14,595,114 | SCHEDULE 13G, 2025-08-25 | 2025-06-30 |
| 11.7% | 14,133,249 | SCHEDULE 13G, 2025-07-24 | 2025-06-30 | |
| 6.88% | 8,313,677 | SCHEDULE 13G, 2025-07-18 | 2025-06-30 | |
| 2.65% | 3,250,900 | SCHEDULE 13D/A, 2025-07-08 | 2025-06-30 | |
| 2.4% | 2,010,733 | SCHEDULE 13G/A, 2026-05-13 | 2026-03-31 |
Holding shares or following this stake? See who's behind TIAN RUIXIANG Holdings Ltd and the warning signs.
Free to see. No signup.
Keep reading
More on TIAN RUIXIANG Holdings Ltd and the records around it.
Companies that share a holder
- Mitchell P. Kopin also filed stake reports on 55 other companies: SCWorx Corp. (Sep 2026), NFT Limited (Aug 2026), Silexion Therapeutics Corp (Aug 2026)
Watch TIAN RUIXIANG Holdings Ltd
Get an email when TIAN RUIXIANG Holdings Ltd files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on TIAN RUIXIANG Holdings Ltd?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on TIAN RUIXIANG Holdings Ltd: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on TIAN RUIXIANG Holdings Ltd covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
8 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Purpose of Transaction (Item 4)
Sinovation Fund IV, L.P.
On May 30, 2025, TIAN RUIXIANG Holdings Ltd, an exempted company with limited liability incorporated under the laws of the Cayman Islands (the "Company" or "TRX"), and its wholly-owned subsidiary, VitaCare Limited, a business company incorporated under the laws of the British Virgin Islands (the "Purchaser"), entered into a share exchange agreement (the "Agreement") with Ucare Inc., an exempted company incorporated under the laws of the Cayman Islands ("Ucare"), all shareholders of Ucare listed in Schedule A of the Agreement (the "Sellers"), including Sinovation Fund IV, L.P., and Mr. Wei Zhu serving as seller representative. Pursuant to the Agreement, the Purchaser has agreed to acquire 100% of Ucare's issued and outstanding shares from Sinovation Fund IV, L.P. and the other Sellers, in exchange for newly-issued class A ordinary shares (the "Class A Ordinary Shares") of a par value of US$0.025 each, of TRX (the "TRX Exchange Shares"). As a result of the transaction, Sinovation Fund IV, L.P. received 25,593,133 TRX Exchange Shares. Except as set forth in this Item 4, the Reporting Persons do not have any present plans or proposals which relate to or would result in any of the transactions of this Item 4.Item 4 of the SCHEDULE 13D filed 2025-07-14
Medata Holdings Limited
On May 30, 2025, TIAN RUIXIANG Holdings Ltd, an exempted company with limited liability incorporated under the laws of the Cayman Islands (the "Company" or "TRX"), and its wholly-owned subsidiary, VitaCare Limited, a business company incorporated under the laws of the British Virgin Islands (the "Purchaser"), entered into a share exchange agreement (the "Agreement") with Ucare Inc., an exempted company incorporated under the laws of the Cayman Islands ("Ucare"), all shareholders of Ucare listed in Schedule A of the Agreement (the "Sellers"), including Medata Holdings Limited , and Mr. Wei Zhu serving as seller representative. Pursuant to the Agreement, the Purchaser has agreed to acquire 100% of Ucare's issued and outstanding shares from Medata Holdings Limited and the other Sellers, in exchange for newly-issued class A ordinary shares (the "Class A Ordinary Shares") of a par value of US$0.025 each, of TRX (the "TRX Exchange Shares"). As a result of the transaction, Medata Holdings Limited received 25,593,133 TRX Exchange Shares. Except as set forth in this Item 4, the Reporting Persons do not have any present plans or proposals which relate to or would result in any of the transactions of this Item 4.Item 4 of the SCHEDULE 13D filed 2025-07-23
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-08 | Mufang Gao | 2.65% | SCHEDULE 13D/A |
| 2025-07-14 | Sinovation Fund IV, L.P. | 21.19% | SCHEDULE 13D |
| 2025-07-18 | Kwong Lung Terence Wong | 6.88% | SCHEDULE 13G |
| 2025-07-23 | Medata Holdings Limited | 16.68% | SCHEDULE 13D |
| 2025-07-24 | Lan Cheng | 11.7% | SCHEDULE 13G |
| 2025-08-25 | Eastern Bell International XXVII Limited | 12.09% | SCHEDULE 13G |
| 2026-02-04 | Mitchell P. Kopin | 9.99% | SCHEDULE 13G |
| 2026-05-13 | Mitchell P. Kopin | 2.4% | SCHEDULE 13G/A |
Questions about who owns TIAN RUIXIANG Holdings Ltd
Who owns TIAN RUIXIANG Holdings Ltd?
On this page, 5 holders' latest ownership filings report 5% or more of TIAN RUIXIANG Holdings Ltd: Sinovation Fund IV, L.P. (21.19%, Schedule 13D, filed 2025-07-14), Medata Holdings Limited (16.68%, Schedule 13D, filed 2025-07-23), Eastern Bell International XXVII Limited (12.09%, Schedule 13G, filed 2025-08-25), Lan Cheng (11.7%, Schedule 13G, filed 2025-07-24) and Kwong Lung Terence Wong (6.88%, Schedule 13G, filed 2025-07-18).
Who are the largest shareholders of TIAN RUIXIANG Holdings Ltd?
By the share each holder's latest filing reports, the largest holders of TIAN RUIXIANG Holdings Ltd on this page are Sinovation Fund IV, L.P. (21.19%), Medata Holdings Limited (16.68%) and Eastern Bell International XXVII Limited (12.09%).
When did Sinovation Fund IV, L.P. buy into TIAN RUIXIANG Holdings Ltd?
The filings give report dates, not purchase dates. The earliest filing from Sinovation Fund IV, L.P. on this page is the Schedule 13D, filed 2025-07-14, reporting 21.19%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 8 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for TIAN RUIXIANG Holdings Ltd. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.